Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.02 USD | -6.96% | -13.40% | -11.01% |
05-09 | Earnings Flash (INMB) INMUNE BIO Reports Q1 Revenue $14,000 | MT |
05-09 | Transcript : INmune Bio, Inc., Q1 2024 Earnings Call, May 09, 2024 |
Sales 2024 * | 56K 4.47M | Sales 2025 * | 58K 4.63M | Capitalization | 198M 15.81B |
---|---|---|---|---|---|
Net income 2024 * | -49M -3.91B | Net income 2025 * | -51M -4.07B | EV / Sales 2024 * | 3,536 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3,414 x |
P/E ratio 2024 * |
-3.72
x | P/E ratio 2025 * |
-3.92
x | Employees | 14 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 67.73% |
Latest transcript on INmune Bio, Inc.
1 day | -6.96% | ||
1 week | -13.40% | ||
Current month | -15.37% | ||
1 month | -3.56% | ||
3 months | -19.13% | ||
6 months | +46.06% | ||
Current year | -11.01% |
Managers | Title | Age | Since |
---|---|---|---|
David Moss
FOU | Founder | 54 | 31/08/15 |
Mark Lowdell
FOU | Founder | 61 | 31/08/15 |
Raymond Tesi
CEO | Chief Executive Officer | 68 | 31/08/15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marcia Allen
BRD | Director/Board Member | 73 | 18/11/19 |
Raymond Tesi
CEO | Chief Executive Officer | 68 | 31/08/15 |
Scott Juda
BRD | Director/Board Member | 53 | 12/03/18 |
Date | Price | Change | Volume |
---|---|---|---|
10/05/24 | 10.02 | -6.96% | 148,564 |
09/05/24 | 10.77 | +2.77% | 107,133 |
08/05/24 | 10.48 | -6.26% | 128,190 |
07/05/24 | 11.18 | -0.18% | 63,843 |
06/05/24 | 11.2 | -3.20% | 119,738 |
Delayed Quote Nasdaq, May 10, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.01% | 198M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- INMB Stock